Kaspersky Plans Share Sale by 2011

Kaspersky Lab, the country's leading provider of programs to stop viruses from attacking mobile phones and personal computers, will sell shares in two to three years to gain funds and raise the profile of its business.

The company will hold its initial public offering on the London Stock Exchange as the costs of listing on the U.S. Nasdaq stock market are too high, chief operating officer Yevgeny Buyakin said in an interview at the Cebit show in Hanover, Germany, on Tuesday.

Kaspersky has enough money to invest in immediate growth and sees its eventual listing as an opportunity to build confidence among clients, he said.

Kaspersky expects orders to total $350 million in 2008, up 70 percent from the previous year, and to grow another $40 million from 2009, Buyakin said.

The has a 4 percent to 5 percent share of the $5 billion antivirus industry, Buyakin said.